ClinicalTrials.gg
CompletedNCT07910669Updated Nov 2, 2026

The Effectiveness of Pilates Exercise on Chronic Low Back Pain of The Older Adults

An interventional study of Pilates exercise in Chronic Low-back Pain, sponsored by National Yang Ming Chiao Tung University. Completed at 1 site in Taiwan. Open to participants aged 40 Years to 69 Years. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by National Yang Ming Chiao Tung University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Apr 2025, registered Jun 2026).
Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
40 Years to 69 Years
Sex
All
01

Study summary

Background: Low-back pain is one of the most common health conditions worldwide. It is defined as pain below the costal margin and above the inferior gluteal folds. Due to aging, older adults experience pain, which can threaten their safety, autonomy, and independence, limit their social interactions, and reduce their quality of life. In exercise therapy, Pilates is considered effective for strengthening core muscles, improving muscle endurance, enhancing spinal control, and promoting trunk stability, thereby minimizing joint load. However, current research has focused on younger populations and lacks detailed descriptions of exercise interventions, making it unclear whether Pilates core exercises would benefit middle-aged and older adults.Therefore, this study incorporates resistance bands and yoga blocks into a Pilates regimen, emphasizing hip mobility exercises and gluteus medius strengthening to enhance the effectiveness of Pilates in treating chronic low back pain. This study aims to design a Pilates exercise therapy program for CLBP that includes hip mobility improvement and gluteus medius training to improve pain, disability level, hip mobility, gluteus medius strength, gluteal endurance, emotional function, participants' ratings of improvement and satisfaction, and participants' intention toward treatment.Purpose: This study targets individuals aged 40 to 69 with chronic low back pain and aims to:Develop an 8-week Pilates core exercise program focusing on gluteal strengthening and increased hip mobility, conducted three times per week for 60 minutes per session, to assess the effectiveness of primary outcome variables (pain, disability) and secondary outcome variables (emotional function, gluteus medius strength, gluteal endurance, hip mobility, satisfaction, self-efficacy).Methods: A single-blind randomized group design will be used in this study. Participants must be aged between 40 and 69 and have had low back pain for more than three months. They will be randomly assigned to either a control group or a Pilates intervention group.Outcome measurement:Outcome measurements include the Visual Analogue Scale (VAS) for pain, the Oswestry Disability Index (ODI), the Beck Depression Inventory (BDI), gluteus medius strength measured by microFET3, hip mobility, self-efficacy for exercise (SEE-C), and the Patient Global Impression of Change (PGIC) scale.

02

Conditions studied

  • Chronic Low-back Pain

Keywords

  • chronic low back pain
  • low back pain
  • Pilates
  • middle-aged and elderly adults
  • hip mobility
  • gluteus medius
  • exercise
  • Pilates exercise
03

In context

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's enrollment of 50 is below the median of 60 across 2,364 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

National Yang Ming Chiao Tung University is the lead sponsor of 208 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Middle-aged and older adults aged 40-69 years.
  2. Chief complaint of recurrent low back pain located below the costal margin and above the gluteal folds, persisting for more than 3 months (12 weeks) without evidence of structural damage.
  3. Visual Analogue Scale (VAS) score for pain intensity greater than 30 mm within the past 7 days.
  4. Chinese version of the Oswestry Disability Index (ODI) score greater than 11 points.
  5. Diagnosis of chronic low back pain (CLBP) confirmed by a physician or a licensed physical therapist with at least 2 years of clinical experience.

Exclusion criteria

Exclusion Criteria

Exclusion criteria will consider both current and past conditions. Participants will be excluded if any of the following apply:

  1. , including:Electrocardiographic changes or history of myocardial infarction、Unstable angina、Uncontrolled cardiac arrhythmias、Aortic stenosis、Uncontrolled heart failure、Acute pulmonary embolism or pulmonary infarction、Acute myocarditis or pericarditis、Suspected or confirmed aortic dissection、Acute systemic infection with fever, generalized pain, or lymphadenopathy
  2. Presence of severe spinal disorders, such as:Fracture

    、Tumor、.Inflammatory disease、Ankylosing spondylitis、Radiculopathy confirmed by neurological examination

  3. History of or scheduled for spinal surgery.
  4. Inability to walk independently (requiring walking aids or assistance from others).
  5. Engagement in regular physical activity, defined as ≥3 sessions per week of leisure-time exercise lasting ≥30 minutes each, within the past 2 weeks.
  6. Diagnosis of cognitive impairment.
  7. Presence of neurological or neuromuscular disorders affecting motor function, including:Multiple sclerosis、Parkinson's disease、Amyotrophic lateral sclerosis (ALS)、Stroke
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Intervention group

    8-week Pilates core exercise program focusing on gluteal strengthening and increased hip mobility, conducted three times per week for 60 minutes per session.

    Behavioral: Pilates exercise

  • No intervention
    Control group

    Participants in the control group will maintain their normal activities of daily living without any experimental intervention.

Interventions

  • BehavioralPilates exercise

    Develop an 8-week Pilates core exercise program focusing on gluteal strengthening and increased hip mobility, conducted three times per week for 60 minutes per session.

06

What researchers measure

Primary outcomes

  1. Pain was measured using a visual analogue scale (VAS).

    The visual analogue scale consists of a 10-cm line, each labelled at the left end as 'no pain' (0) and at the right end as 'very severe pain' (10).Patients were asked to draw a vertical mark on each line(Delgado et al., 2018).

    Time frame: A total of three measurements were taken (one baseline and two post-tests at 4 and 8 weeks post-intervention).

  2. Disability was assessed using the Oswestry Disability Index (ODI).

    Disability was assessed using the Oswestry Disability Index. It contains ten items related to limitations in daily life activities, rating each on a 0-5 point scale; the points are added together and converted into a percentage:Minimally disabled (0-10%), moderately disabled(20-40%), severely disabled (40-60%), crippled (60-80%) or bedbound (80-100%)(Rocchi et al., 2005).

    Time frame: A total of three measurements were taken (one baseline and two post-tests at 4 and 8 weeks post-intervention).

Secondary outcomes

  1. The Beck Depression Scale was used to measure the severity of depressive symptoms among patients(Dworkin et al., 2008).

    The BDI consists of 21 groups of four statements designed to assess the severity of current depressive symptoms, with a total score ranging from 0 to 63. Beck and Steer suggested that scores below 10 should be considered to reflect "mild or none" depression, 10 to 18, 19 to 29, and 30 to 63 to reflect "mild to moderate," "moderate to severe," and "severe" depression, respectively (Beck et al., 1988).

    Time frame: A total of three measurements were taken (one baseline and two post-tests at 4 and 8 weeks post-intervention).

  2. Muscle power measured by microFET3.

    Muscle power measured by microFET3. Patient Position: Lying on their side with the test leg up. At the start of the test, the limb is slightly extended beyond the midline, and the pelvis is slightly rotated forward. The lower leg is bent for stability. Therapist Position: Standing behind the patient. The hand applying resistance is placed on the lateral side near the ankle. The hand used to palpate the gluteus medius is placed proximal to the greater trochanter of the femur. Instructions to the Patient: "Lift your leg. Hold it. Don't let me press it down."

    Time frame: A total of three measurements were taken (one baseline and two post-tests at 4 and 8 weeks post-intervention).

  3. Hip mobility measured using a GEMRED brand, model: 82311-300 electronic protractor.

    The range of free movement a joint can make during body movement. It is the number of arc degrees of movement between the start and end of a movement on a specific plane.

    Time frame: A total of three measurements were taken (one baseline and two post-tests at 4 and 8 weeks post-intervention).

  4. The Chinese version of the self-efficacy for exercise (SEE-C) scale

    The Chinese version of the self-efficacy for exercise (SEE-C) scale was designed to test people's confidence to continue exercising in the face of barriers to exercise (Lee et al., 2009).It attempts to predict and explain human behavior by referencing an individual's assessment of their ability or effectiveness in successfully performing a specific behavior. Self-efficacy theory suggests that the stronger an individual's self-efficacy and outcome expectations, the more likely they are to initiate and persist in a specific activity. Self-efficacy theory includes self-efficacy expectations, which are an individual's beliefs about their ability to perform a series of actions to achieve a desired outcome, and the belief that their actions will produce a certain result.

    Time frame: A total of two measurements were taken ( baseline and 8 weeks post-intervention).

  5. Patient Global Impression of Change (PGIC) scale

    Symptom improvement satisfaction is one of the core outcome indicators of overall improvement after treatment. This study used the Patient Global Impression of Change scale (PGIC). Participants were required to rate on a scale from -5 to 5, with each number representing a different condition: 0 represents "no change," -5 represents "very bad," -4 to -1 represent varying degrees of "worse," with lower numbers indicating a worse condition. 1 to 4 represent varying degrees of "recovery," with higher numbers indicating a better condition. 5 represents "complete recovery," meaning the patient has fully recovered to a normal state (Kamper et al., 2009). The Patient-Assessed Overall Improvement Scale is completed by the patient themselves to self-assess the severity of the disease or the effectiveness of the treatment.

    Time frame: A total of two measurements were taken ( 4 and 8 weeks post-intervention).

07

Study locations

1 site
  • Yoga Studio
    New Taipei City, Tamsui Dist 251026, Taiwan
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2025 to primary completion in Feb 2026, 10 months.

Of 1,231 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 10 months is close to that.

Counting every sponsor, half of 1,286 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 9, 2026
First posted
Nov 2, 2026
StartActual
Apr 1, 2025
Primary completionActual
Feb 1, 2026
CompletionActual
Feb 1, 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07910669
Responsible party
Sponsor
First posted
Nov 2, 2026
Start date
Apr 1, 2025
Primary completion
Feb 1, 2026
Completion
Feb 1, 2026
Last update
Nov 2, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion